Northumbria University
Newcastle upon Tyne, Tyne and Wear, NE1 8ST, United Kingdom
NCT Number: NCT01075932
DHA has previously been shown to increase regional cerebral blood flow response to tactile stimulation in aged monkeys; modulation of cerebral blood flow in humans has yet to be demonstrated. Given that the brain relies on a constant supply of blood-borne metabolic substrates (e.g. glucose, oxygen), increasing regional cerebral blood flow may also have an impact on cognitive function. The current study aims to investigate the effects of two doses of DHA-rich fish oil on task-related cerebral hemodynamic response and cognitive performance in healthy adults.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
Newcastle upon Tyne, Tyne and Wear, NE1 8ST, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Either 1 g or 2 g DHA-rich fish oil taken daily for 12 weeks. Participants in the 1 g group will also consume 1 g olive oil placebo capsules per day to maintain double blind.
2 g placebo (olive oil) taken daily for 12 weeks
Time frame: 12 weeks
Cerebral blood flow will be assessed using Near Infrared Spectroscopy while participants complete a series of cognitive tasks.
Time frame: 12 weeks
Cognitive function will be assessed using a series of tasks that evaluate working memory, attention and executive function.
Northumbria University
Other
The Cognitive And Cerebral Hemodynamic Effects Of DHA-Rich Fish Oil: A Dose-Ranging Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02893553
Autonomic Dysreflexia, Autonomic Integrity
West Orange, New Jersey, United States
View Trial DetailsNCT03037879
Blood Pressure, Central Nervous System Diseases
West Orange, New Jersey, United States
View Trial DetailsNCT04477018
Cerebral Blood Flow, Cognitive Function
Newcastle upon Tyne, United Kingdom
View Trial DetailsNCT01185379
Cerebral Blood Flow, Cognitive Function
Newcastle upon Tyne, Tyne and Wear, United Kingdom
View Trial Details